Sanc.Kl
SANC.KL operates in the healthcare equipment sector, providing medical devices and related technologies to healthcare providers and institutions.
Business. SANC.KL operates in the healthcare equipment sector, providing medical devices and related technologies to healthcare providers and institutions.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
SANC.KL operates in the healthcare equipment sector, providing medical devices and related technologies to healthcare providers and institutions.
SANC.KL maintains a strong liquidity position with a current ratio of 10.18, indicating a high ability to meet short-term obligations. However, the company reported negative net cash of MYR -391,670 (calculated as cash and equivalents minus long-term debt), which raises concerns about its liquidity resilience. The company's free cash flow was negative at MYR -469,490, driven by significant capital expenditures of MYR -3,277,970, suggesting heavy reinvestment in its operations.
Profitability metrics for SANC.KL are robust, with a return on equity (ROE) of 9.8% and a return on assets (ROA) of 9.35%. These figures suggest the company is effectively utilizing its equity and asset base to generate returns. Gross profit of MYR 2,136,490 and operating income of MYR 2,192,170 indicate strong cost control and operational efficiency. However, the company's performance should be benchmarked against industry medians to determine its relative standing.
Geographic and segment exposure data is not available in the provided input, so revenue concentration cannot be assessed. The company's business model appears to be centered on healthcare equipment, but the absence of segment-specific revenue data limits the ability to evaluate diversification.
SANC.KL reported revenue of MYR 3,456,850 in the latest period, but no growth trajectory data is available for the current or next fiscal year. The company's capital expenditures suggest a focus on long-term growth, but the negative free cash flow indicates that this growth is currently being funded through operational cash flow rather than excess liquidity.
The risk assessment for SANC.KL indicates a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio is 0.0, reflecting a conservative capital structure with no long-term debt obligations. However, the negative net cash position raises concerns about the company's ability to fund operations without external financing.
Recent events and filings are not detailed in the input data, so no specific recent developments can be cited. The company's financial disclosures suggest a focus on maintaining operational efficiency and investing in long-term growth, but the absence of recent events or transcripts limits the ability to assess strategic direction.
- SANC.KL has a strong current ratio of 10.18, indicating a high ability to meet short-term obligations.
- The company's ROE of 9.8% and ROA of 9.35% suggest effective use of equity and assets to generate returns.
- SANC.KL reported negative free cash flow of MYR -469,490, driven by significant capital expenditures of MYR -3,277,970.
- The company has no long-term debt, resulting in a debt-to-equity ratio of 0.0.
- SANC.KL has a medium liquidity risk and a low dilution risk, but its negative net cash position raises concerns about liquidity resilience.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- SANC.KL Market data — financials · 2026-05-29